{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:11:46Z","timestamp":1773051106368,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Ningxia Hui Autonomous Region Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.numecd.2024.103800","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T07:56:54Z","timestamp":1732089414000},"page":"103800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The time-averaged serum uric acid can better predict the prognosis of IgA nephropathy"],"prefix":"10.1016","volume":"35","author":[{"given":"Chenchen","family":"Qi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9626-557X","authenticated-orcid":false,"given":"Xiaoling","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.numecd.2024.103800_bib1","first-page":"694","article-title":"Intercapillary deposits of IgA-IgG","volume":"74","author":"BergerJ","year":"1968","journal-title":"J Urol Nephrol"},{"issue":"1","key":"10.1016\/j.numecd.2024.103800_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2015.322","article-title":"The MEST score provides earlier risk prediction in lgA nephropathy","volume":"89","author":"Barbour","year":"2016","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.numecd.2024.103800_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jch.12636","article-title":"Could uric acid Be considered a cardiovascular risk factor?","volume":"17","author":"Rodriguez-Arias","year":"2015","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.numecd.2024.103800_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2024.103800_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.numecd.2024.103800_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/HJH.0000000000002354","article-title":"Long-term blood pressure behavior and progression to end-stage renal disease in patients with imm unoglobulin A nephropathy: a single-center observational study in Ita ly","volume":"38","author":"Russo","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2024.103800_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1060526","article-title":"Blind spot in the radar of MEST-C score: type and severity of tubulointerstitial nephritis in IgA nephropathy","author":"Asrar","year":"2023","journal-title":"Internet J Nephrol"},{"issue":"1","key":"10.1016\/j.numecd.2024.103800_bib8","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1080\/0886022X.2019.1635029","article-title":"Association between lifestyle,gender an d risk for developing end-stage renal failure in IgA nephropathy:a ca se-control study within 10 years","volume":"41","author":"Huang","year":"2019","journal-title":"Ren Fail"},{"key":"10.1016\/j.numecd.2024.103800_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000529822","article-title":"Clinicopathological characteristics and outcomes of immunoglobulin A nephropathy with different types of dyslipidemia: a retrospective single-center study","volume":"48","author":"Liu","year":"2023","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1016\/j.numecd.2024.103800_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2021.2019589","article-title":"Is hyperuricemia an independent prognostic factor for IgA nephropathy: a systematic review and meta-analysis of observational cohort studies","volume":"44","author":"Zhang","year":"2022","journal-title":"Ren Fail"},{"issue":"9","key":"10.1016\/j.numecd.2024.103800_bib11","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1007\/s11255-022-03125-4","article-title":"Hyperuricemia aggravates the progression of IgA nephropathy","volume":"54","author":"Geng","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.numecd.2024.103800_bib12","first-page":"53","article-title":"A 5-year follow-up study of patients with IgA nephropathy complicated with hyperuricemia","volume":"27","author":"Jiang","year":"2011","journal-title":"Chinese Journal of Nephrology"},{"issue":"24","key":"10.1016\/j.numecd.2024.103800_bib13","article-title":"Lower serum uric acid level predicts mortality in dialysis patients","volume":"95","author":"Bae","year":"2016","journal-title":"Medici ne"},{"issue":"2","key":"10.1016\/j.numecd.2024.103800_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000489962","article-title":"Uric acid as a predictor of immunoglobulin A nephropathy progression:A cohort study of 1965 C ases","volume":"48","author":"Zhu","year":"2018","journal-title":"Am J Nephrol"},{"issue":"20","key":"10.1016\/j.numecd.2024.103800_bib15","first-page":"2473","article-title":"Expert consensus on the diagno sis and treatment of hyperuricemia and related diseases","volume":"130","year":"2017","journal-title":"Chin J Intern Med"},{"issue":"9","key":"10.1016\/j.numecd.2024.103800_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estima te glomerular filtration rate","volume":"15","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2024.103800_bib17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy:rationale, clinicopathological correlations,and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.numecd.2024.103800_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.026","article-title":"Hyperuricemia induces hypertension thro ugh activation of renal epithelial sodium channel (ENaC)","volume":"65","author":"Xu","year":"2016","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.numecd.2024.103800_bib19","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.numecd.2020.07.038","article-title":"Increased serum uric acid levels are associated to renal arteriolopathy and predict poor outcome in IgA nephropathy","volume":"30","author":"Russo","year":"2020","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.numecd.2024.103800_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.kint.2020.05.056","article-title":"Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease","volume":"98","author":"Ponticelli","year":"2020","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.numecd.2024.103800_bib21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/jcm9010176","article-title":"The effects of hyperuricemia on the prognosis of IgA nephropathy are more potent in females","volume":"9","author":"Oh","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.numecd.2024.103800_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.atherosclerosis.2021.06.908","article-title":"Detailed association between serum uric acid levels and the incidence of chronic kidney disease stratified by sex in middle-aged adults","volume":"330","author":"Nakayama","year":"2021","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.numecd.2024.103800_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118031","article-title":"Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prosp ective cohort study","volume":"10","author":"Kanda","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.numecd.2024.103800_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000355779","article-title":"Clinical and biological determinants of kidney outcomes in a population-based cohort study","volume":"39","author":"Guessous","year":"2014","journal-title":"Kidney Blood Press Res"},{"issue":"4","key":"10.1016\/j.numecd.2024.103800_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.exger.2008.01.006","article-title":"Uric acid as a risk factor fo r progression of non-diabetic chronic kidney disease? The mild to mo derate kidney disease (MMKD) study","volume":"43","author":"Sturm","year":"2008","journal-title":"Exp Gerontol"},{"issue":"6","key":"10.1016\/j.numecd.2024.103800_bib26","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10157-015-1120-4","article-title":"Serum uric acid and the in cidence of CKD and hypertension","volume":"19","author":"Kuriyama","year":"2015","journal-title":"Clin Exp Nephrol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324004344?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324004344?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T20:17:10Z","timestamp":1741810630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475324004344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0939475324004344"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.103800","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The time-averaged serum uric acid can better predict the prognosis of IgA nephropathy","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.103800","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"103800"}}